Like you, EXR makes up the majority of my portfolio too as I was...

Like you, EXR makes up the majority of my portfolio too as I was fortunate enough to jump on this train early when the share price was a fraction of its current price. Despite EXR comprising the bulk of my portfolio, I am extremely comfortable with my holdings given our highly prospective tenements/PSC's, the promising results to date and in particular, our quality directors.

I believe the following quote is apt for our situation, given Neil Young & Co. definitely know what they're doing:



Although the share price is multiples of where it was at this time last year, I still think its early days yet with respect to the potential rewards shareholders can expect in 2021. We now have over 8m in the kitty to conduct further drills and tests all over our PSC and if results are similar to what we've already achieved and we can prove up/increase our resource figures, I see no reason why our share price can't be 50c plus this time next year (approx. 400m market cap).

IMO, we've found our golden ticket with EXR and patience is the key going forward. Not all drill results will be spectacular/commercial, however, with our quality management at the the helm, I have faith they will make the right decisions which will ultimately lead to the company being taken over, a la QGC.

GLTAH and best wishes for the new year!